Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals, the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. The company's mission is to provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders and other stakeholders. In this report, we have tried to focus on the financial performance of the company during the fiscal year of 2006-2010. We have used financial ratios to determine its performance in short term and long term period. The firm had a strong financial backbone as it uses less debt for investment, uses its asset efficiently for producing goods. Sales had increases on regular basis over past the years. In one word based on our analysis this firm can be an example in certain financial segment for other company. Though, the firm pays fewer cash dividends than past fiscal years, which might be disliked by investors. But it must be added that the company had been increasing it’s the number of outstanding share regularly and also provide bonus share to its shareholder. The company’s fiscal year is based on April to March. And regularly hold annual general meeting and publishes financial report both annually, half yearly and quarterly.
SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71...